Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1155 of 5804
-
Smarter surgery may cut reflux after achalasia procedure
Disease control Not yet recruitingPeroral endoscopic myotomy (POEM) is an effective, minimally invasive treatment for achalasia, offering excellent rates of symptom relief. However, a significant drawback is the high incidence of gastroesophageal reflux disease (GERD) following the procedure. One proposed technic…
Phase: NA • Sponsor: University of California, Irvine • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
Can a smartphone app keep heart attack patients out of the ER?
Disease control Not yet recruitingHeart attacks are one of the top causes of death in Canada, with over 2,100 cases treated each year in Manitoba. Even though hospital care has improved, the period after going home is still risky. Many patients feel anxious and unsure about their recovery, and without enough supp…
Phase: NA • Sponsor: St. Boniface Hospital • Aim: Disease control
Last updated Jun 26, 2026 16:34 UTC
-
Shocking new hope: brain zaps may restore swallowing after stroke
Symptom relief Not yet recruitingIt is estimated that 400,000 to 800,000 people worldwide develop neurogenic dysphagia annually. Stroke represents the most common etiology, with approximately 65% of acute stroke patients experiencing pharyngeal swallowing difficulties. Clinical manifestations of dysphagia vary w…
Phase: NA • Sponsor: Zhejiang Provincial People's Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 07:54 UTC
-
New rabies vaccine could cut shots from three visits to one
⭐️ VACCINE ⭐️ Not yet recruitingThis is a phase II randomised, open-label study to assess the safety and immunogenicity of coadministration of the candidate rabies vaccine ChAdOx2 RabG and licensed vaccine in healthy adults (18-45 years old). ChAdOx2 RabG will be administered intramuscularly and licensed rabies…
Phase: PHASE2 • Sponsor: University of Oxford • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 07:57 UTC
-
New Pill-and-IV combo takes on bile duct cancer in small trial
Disease control Recruiting nowParticipants are eligible for this study who were treated for advanced biliary tract cancer (BTC) but the treatment either did not make the cancer better or is no longer working. The treatment for patients whose advanced BTC either did not make the cancer better or is no longer w…
Phase: PHASE2 • Sponsor: Case Comprehensive Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
Hip fracture patients at heart risk may benefit from dual blood thinners
Disease control Not yet recruitingA third of patients undergoing surgery for a hip fracture develop a myocardial injury (i.e., an elevated troponin measurement), and these patients are at substantial risk of death and morbidity. Current prophylaxis strategies focus on preventing venous thromboembolism (VTE); howe…
Phase: PHASE3 • Sponsor: McMaster University • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
Robot surgeons take on breast cancer: will they beat the scalpel?
Symptom relief Recruiting nowNipple-sparing mastectomy (NSM) preserves the nipple-areolar complex (NAC) and is associated with improved cosmetic outcomes, body image, and patient satisfaction compared with more ablative techniques. Its use has expanded in both therapeutic and risk-reducing settings, includin…
Phase: NA • Sponsor: Beaumont Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 13:01 UTC
-
Stem cells take on Parkinson's: first safety trial begins
Disease control Not yet recruitingThis study, through different administration methods, adopted a randomized, double-blind, placebo-controlled trial design to evaluate the safety and tolerability of human umbilical cord mesenchymal stem cells (hUC-MSCs) in patients with Parkinson's disease, explore their initial …
Phase: PHASE1 • Sponsor: Liaoning Medical Diagnosis and Treatment Technology Research and Development Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
New surgery aims to stop pancreatic cancer from coming back
Disease control Recruiting nowPancreatic ductal adenocarcinoma (PDAC) has poor prognosis due to high recurrence rates after standard pancreaticoduodenectomy (PD). The concept of Total Mesopancreas Excision (TMpE), analogous to total mesorectal excision, aims to improve oncological outcomes by achieving higher…
Phase: NA • Sponsor: Minia University • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
New drug shows promise for ulcerative colitis in early trial
Disease control OngoingThis phase 2 study is being conducted to evaluate the efficacy, safety and pharmacokinetics of SHR-1139 in patients with moderate to severe active ulcerative colitis. This study consists 2 treatment parts, the Induction treatment part and Maintenance treatment part. The periods …
Phase: PHASE2 • Sponsor: Guangdong Hengrui Pharmaceutical Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
New drug combo aims to shrink liver tumors in kidney cancer patients
Disease control Not yet recruitingThis is an open-label, single-arm, prospective, multicenter clinical study designed to evaluate the efficacy and safety of envafolimab in combination with lenvatinib for the treatment of patients with clear cell renal cell carcinoma (ccRCC) accompanied by liver metastases. The De…
Phase: PHASE2 • Sponsor: Fudan University • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
New Pain-Zapping technique could ease debilitating facial pain
Symptom relief Not yet recruitingThis study aims to compare between the Efficacy and safety of irregular pulsed radiofrequency STP versus regular pulsed radiofrequency to the gasserian ganglion for treatment of primary trigeminal neuralgia.
Phase: NA • Sponsor: Sohag University • Aim: Symptom relief
Last updated Jun 27, 2026 08:07 UTC
-
CBD oil put to the test for breast cancer joint pain
Symptom relief Not yet recruitingPhase III, single-center, randomized, double-blind, placebo-controlled, 2x2 cross- over study, assessing the efficacy of CBD in patients with early HR+ BC, presenting aromatase inhibitor-related musculoskeletal pain
Phase: PHASE3 • Sponsor: Gustave Roussy, Cancer Campus, Grand Paris • Aim: Symptom relief
Last updated Jun 27, 2026 08:01 UTC
-
Stem-Cell liver machine tested in 12 patients
Disease control Recruiting nowThe goal of this clinical trial is to evaluate the safety and tolerability of a novel bioartificial liver (CiPS-BAL) in patients with liver failure or small-for-size syndrome. The study will also collect preliminary data on clinical outcomes and laboratory parameters during treat…
Phase: PHASE1, PHASE2 • Sponsor: Beijing Friendship Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC
-
Engineered immune cells take aim at Hard-to-Treat cancers
Disease control Recruiting nowThis clinical trial is a prospective, dose-escalation, multicenter, single- arm, Phase 1 clinical trial to evaluate the safety, tolerability, PK and preliminary clinical activity of PRAME Antigen-targeted TCR-T Cells (NW-101C) infusion in patients with previously heavily treated,…
Phase: PHASE1 • Sponsor: Neowise Biotechnology • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Should liver cancer patients get surgery after drugs work? new study aims to find out
Knowledge-focused ENROLLING_BY_INVITATIONThis study aims to further explore the survival benefits of surgical resection after achieving CR in initial uHCC after systemic treatment and the timing of discontinuing systemic treatment
Sponsor: Fujian Provincial Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:05 UTC
-
Smart radiation: daily adjustments may spare prostate cancer patients from side effects
Symptom relief Recruiting nowThis clinical trial studies the side effects of image-guidance and online adaptation with stereotactic body radiation therapy (SBRT) for the treatment of patients with prostate adenocarcinoma that has not spread to other parts of the body (localized). Image-guided SBRT is a stand…
Phase: NA • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Symptom relief
Last updated Jun 27, 2026 09:03 UTC
-
New bead therapy may improve liver cancer treatment after shunt procedure
Disease control Recruiting nowThis is a Phase 3, open-label, multicenter, randomized controlled clinical trial designed to evaluate the efficacy and safety of Drug-Eluting Bead Transarterial Chemoembolization (DEB-TACE) compared with Conventional Transarterial Chemoembolization (cTACE) in patients with hepato…
Phase: PHASE3 • Sponsor: First Affiliated Hospital, Sun Yat-Sen University • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
Eye ultrasound could speed up brain swelling detection
Diagnosis Recruiting nowTimely detection of signs of raised intracranial pressure or persistent inflammation within the meninges can expedite therapeutic decisions improving the prognosis of patients with brain damage. Optic nerve ultrasonography provides a user-friendly, safe, low-cost, and non-invasiv…
Sponsor: Spitalul Clinic de Boli Infecțioase și tropicale "Dr. Victor Babeș" • Aim: Diagnosis
Last updated Jun 27, 2026 08:10 UTC
-
Music and fun activities may speed up stroke rehab
Symptom relief Recruiting nowThe goal of this clinical trial is to learn whether adding group leisure activities and musical training can help people recover better after a stroke during their hospital rehabilitation. The study will include adults who had a recent stroke and are staying in the neurological r…
Phase: NA • Sponsor: Escola Universitària d'Infermeria i Teràpia Ocupacional de Terrassa • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC